Oklahoma Senate Bill SB146

Oklahoma 2024 Regular Session

• Introduced: 2/6/23
• Refer: 2/7/23

Caption

Prescription drugs; creating the Access to Lifesaving Medicines Act. Effective date.

Impact

The legislation would significantly change the current framework surrounding prescription drug pricing and cost-sharing. By mandating that health insurers and pharmacy benefit managers not impose an excessive cost burden on patients, SB146 seeks to protect consumers from unexpected out-of-pocket expenses when acquiring necessary medications. It also establishes a structure for determining the appropriate levels of cost-sharing, thus promoting transparency in the way prescription drug costs are handled across the state’s health care system.

Summary

Senate Bill 146, known as the Access to Lifesaving Medicines Act, is aimed at addressing issues related to the cost of prescription drugs in Oklahoma. The bill prohibits health insurers and pharmacy benefits managers from imposing excessive costs on individuals obtaining prescription medications, specifically ensuring that the cost-sharing elements such as co-payments and co-insurance do not exceed certain limits. Furthermore, the bill requires that certain rebates be offered to health benefit plans, which could lead to reduced out-of-pocket expenses for enrollees when purchasing prescription medications.

Contention

While the bill presents a comprehensive approach to improving access to lifesaving medications, it may also face scrutiny from stakeholders within the pharmaceutical and insurance industries. Health insurers and pharmacy benefits managers might argue that the restrictions placed upon them could limit their flexibility to negotiate prices and manage drug formularies. Additionally, some legislators may express concern over potential unintended consequences, such as increases in insurance premiums or disruption in the relationships between insurers and pharmacies as they adapt to these new requirements.